ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.

Alison M Nagle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.